Lars Fugger

22.3k total citations · 7 hit papers
168 papers, 15.5k citations indexed

About

Lars Fugger is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Lars Fugger has authored 168 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Immunology, 34 papers in Radiology, Nuclear Medicine and Imaging and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Lars Fugger's work include T-cell and B-cell Immunology (72 papers), Immunotherapy and Immune Responses (51 papers) and Immune Cell Function and Interaction (35 papers). Lars Fugger is often cited by papers focused on T-cell and B-cell Immunology (72 papers), Immunotherapy and Immune Responses (51 papers) and Immune Cell Function and Interaction (35 papers). Lars Fugger collaborates with scholars based in Denmark, United Kingdom and United States. Lars Fugger's co-authors include Manuel A. Friese, Calliope A. Dendrou, Lise Torp Jensen, Arne Svejgaard, Matthew Craner, Denis Burdakov, Jamie Rossjohn, Lars Siim Madsen, Margaret M. Esiri and E. Yvonne Jones and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Lars Fugger

166 papers receiving 15.2k citations

Hit Papers

Immunopathology of multiple... 1993 2026 2004 2015 2015 2007 1998 1993 2014 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunopathology of multiple sclerosis
    2015 1.6k citations Calliope A. Dendrou, Lars Fugger et al. profile →
  2. Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
    2007 951 citations John S. Tzartos, Manuel A. Friese et al. American Journal Of Pathology profile →
  3. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
    1998 914 citations Øyvind Molberg, Stephen N. McAdam et al. Nature Medicine profile →
  4. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
    1993 794 citations Lars Fugger et al. profile →
  5. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
    2014 455 citations Manuel A. Friese, Lars Fugger et al. profile →
  6. HLA variation and disease
    2018 455 citations Calliope A. Dendrou, Jamie Rossjohn et al. profile →
  7. The immunology of multiple sclerosis
    2022 196 citations Kathrine E. Attfield, Lise Torp Jensen et al. profile →

Peers

Lars Fugger
Samia J. Khoury United States
Jorge R. Oksenberg United States
Scott S. Zamvil United States
Roland Liblau France
Arthur A. Vandenbark United States
Claude C.A. Bernard Australia
Stephen L. Hauser United States
Jan Bauer Austria
Edgar Meinl Germany
David R. Hinton United States
Samia J. Khoury United States
Lars Fugger
Citations per year, relative to Lars Fugger Lars Fugger (= 1×) peers Samia J. Khoury

Countries citing papers authored by Lars Fugger

Since Specialization
Citations

This map shows the geographic impact of Lars Fugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Fugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Fugger more than expected).

Fields of papers citing papers by Lars Fugger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Fugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Fugger. The network helps show where Lars Fugger may publish in the future.

Co-authorship network of co-authors of Lars Fugger

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Fugger. A scholar is included among the top collaborators of Lars Fugger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Fugger. Lars Fugger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen, Lise Torp, Kathrine E. Attfield, & Lars Fugger. (2024). A repair pathway lost in multiple sclerosis provides a new drug opportunity. Nature Immunology. 25(3). 385–386. 1 indexed citations
2.
Kaufmann, Max, Fabian Coscia, Calliope A. Dendrou, et al.. (2022). Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nature Neuroscience. 25(7). 944–955. 81 indexed citations
3.
Kvastad, Linda, Ludvig Larsson, Alexander Stuckey, et al.. (2021). The spatial RNA integrity number assay for in situ evaluation of transcriptome quality. Communications Biology. 4(1). 57–57. 21 indexed citations
4.
Cortés, Adrián, Patrick K. Albers, Calliope A. Dendrou, Lars Fugger, & Gil McVean. (2019). Identifying cross-disease components of genetic risk across hospital data in the UK Biobank. Nature Genetics. 52(1). 126–134. 23 indexed citations
5.
Ooi, Joshua D., Jhih‐Hang Jiang, Peter J. Eggenhuizen, et al.. (2019). A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nature Communications. 10(1). 3392–3392. 45 indexed citations
6.
Pré, M. Fleur du, Jorunn Stamnæs, Chakravarthi Kanduri, et al.. (2019). B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2. The Journal of Experimental Medicine. 217(2). 42 indexed citations
7.
Cortés, Adrián, Calliope A. Dendrou, Allan Motyer, et al.. (2017). Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank. Nature Genetics. 49(9). 1311–1318. 41 indexed citations
8.
McKee, Justin, John Elston, Nikos Evangelou, et al.. (2016). Amiloride does not protect retinal nerve fibre layer thickness following acute optic neuritis; result from a phase II, double blind, randomised controlled trial.. Multiple Sclerosis Journal. 22. 21–22. 2 indexed citations
9.
Arun, Tarunya, Valentina Tomassini, Emilia Sbardella, et al.. (2013). Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain. 136(1). 106–115. 111 indexed citations
10.
Tzartos, John S., Matthew Craner, Manuel A. Friese, et al.. (2011). IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain. American Journal Of Pathology. 178(2). 794–802. 113 indexed citations
11.
Karnani, Mahesh, Anne Venner, Lise Torp Jensen, Lars Fugger, & Denis Burdakov. (2010). Direct and indirect control of orexin/hypocretin neurons by glycine receptors. The Journal of Physiology. 589(3). 639–651. 28 indexed citations
12.
Call, Melissa, Xuechao Xing, Gregory D. Cuny, et al.. (2009). In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange. The Journal of Immunology. 182(10). 6342–6352. 28 indexed citations
13.
Craner, M, Manuel A. Friese, Ruth Etzensperger, et al.. (2008). Acid sensing ion channel 1 contributes to axonal degeneration in autoimmune CNS inflammation and provides a novel target for neuroprotection in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 79. 339–339. 1 indexed citations
14.
Williams, Rhîannan H., Lise Torp Jensen, Alexei Verkhratsky, Lars Fugger, & Denis Burdakov. (2007). Control of hypothalamic orexin neurons by acid and CO 2. Proceedings of the National Academy of Sciences. 104(25). 10685–10690. 254 indexed citations
15.
Dzhambazov, Balik, Kutty Selva Nandakumar, Jan Kihlberg, et al.. (2006). Therapeutic Vaccination of Active Arthritis with a Glycosylated Collagen Type II Peptide in Complex with MHC Class II Molecules. The Journal of Immunology. 176(3). 1525–1533. 57 indexed citations
16.
Rich, Cathleen, Jason M. Link, Alex Zamora, et al.. (2004). Myelin oligodendrocyte glycoprotein‐35–55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA‐DR2‐transgenic mice. European Journal of Immunology. 34(5). 1251–1261. 47 indexed citations
17.
18.
Fridkis‐Hareli, Masha, Laura Santambrogio, Joel N. H. Stern, et al.. (2002). Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. Journal of Clinical Investigation. 109(12). 1635–1643. 17 indexed citations
19.
Lang, Heather, Helle J. Jacobsen, Shinji Ikemizu, et al.. (2002). A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immunology. 3(10). 940–943. 441 indexed citations
20.
Molberg, Øyvind, Stephen N. McAdam, Roman Körner, et al.. (1998). Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine. 4(6). 713–717. 914 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samia J. Khoury Breakdown of academic impact, for papers by Jorge R. Oksenberg Breakdown of academic impact, for papers by Scott S. Zamvil Breakdown of academic impact, for papers by Roland Liblau Breakdown of academic impact, for papers by Arthur A. Vandenbark Breakdown of academic impact, for papers by Claude C.A. Bernard Breakdown of academic impact, for papers by Stephen L. Hauser Breakdown of academic impact, for papers by Jan Bauer Breakdown of academic impact, for papers by Edgar Meinl Breakdown of academic impact, for papers by David R. Hinton
Rankless by CCL
2026